The National Institute of Mental Health is currently enrolling participants in 3 studies of depression.
Teen Depression Study
Are you a teen or parent of a teen diagnosed with depression by a pediatrician or other medical provider? The NIMH is conducting a nation-wide study of depression in teens ages 11 to 17. The study will include various assessments, including brain imaging. Eligible participants may receive evidence-based cognitive behavioral therapy and standard medication if indicated. Read about the study here: Finding causes and treating depression in teenagers. For more information call 1-301-827-1350 or email firstname.lastname@example.org.
Depression, Repeated Doses of Ketamine, and Neuroimaging
NIMH is conducting a study to evaluate the rapid and sustained antidepressant effects of repeat doses of ketamine. This 14- to 20-week inpatient study is enrolling eligible depressed adults, ages 18 to 65 from across the United States, who are free of other serious medical conditions. NIMH will pay for travel to the NIH Clinical Center in Bethesda, MD. There is no cost to participate and compensation is provided. Read about the study here: Depression, Repeated Doses of Ketamine, and Neuroimaging. For more information, call 1-877-646-3644 or email email@example.com.
Depression and Brain Function
Inpatient and/or Outpatient study: 8 weeks, and 3 once-a-month follow-up visits or phone calls. This depression research study tests the effects of the combination of transcranial magnetic stimulation (TMS) and psychotherapy on brain function. Participation includes research evaluations, brain scans, and active TMS and psychotherapy, or inactive TMS and psychotherapy. Recruiting ages 18 to 65 with major depressive disorder, who are free of other serious medical conditions. If you are currently taking antidepressants, you may still be eligible. Read about the study here: Depression, TMS, Psychotherapy and Brain Function. For more information, call 1-877-646-3644 or email firstname.lastname@example.org .